Many civil cases turn less on what happened than on what it means. In a drug injury case, the question may be whether a medication can cause a particular disease at all. In a property dispute with the government, the question may be what a piece of land was worth on the day it was taken. Neither question can be answered by ordinary witnesses. Both depend on expert testimony, and both show how much a case can rise or fall on the strength of specialized evidence.
Indiana courts, and the federal courts that hear many large drug cases, apply rules designed to keep unreliable expert opinions away from juries. Those rules matter in very different kinds of cases, from claims involving popular diabetes and weight-loss drugs to disputes over highway projects that take part of a family’s property.
Why Expert Rules Matter So Much
Expert witnesses are allowed to offer opinions that ordinary witnesses cannot, which gives their testimony unusual weight. Courts therefore act as gatekeepers. Firms that handle both complex injury litigation and property cases, CohenMalad, LLP among them, deal with these gatekeeping rules across very different subject areas, since the same basic question applies to a toxicologist and an appraiser: the opinion must rest on sufficient facts and reliable methods, applied properly to the case.
In federal court, Federal Rule of Evidence 702 governs that question. The rule was amended in December 2023 to clarify that the party offering an expert must show by a preponderance of the evidence that the testimony meets the reliability requirements, and that the expert’s opinion reflects a reliable application of the methods to the facts. Indiana has its own Evidence Rule 702, which also requires that expert testimony rest on reliable scientific principles, and Indiana courts have found federal reliability decisions helpful without formally adopting every federal test.
Causation Evidence in Drug Injury Claims
Drug injury claims usually require two kinds of causation proof. General causation asks whether the drug is capable of causing the type of injury alleged in the population at large. Specific causation asks whether it caused this particular person’s injury. Experts typically draw on clinical trials, observational studies, animal research, adverse event reports, and the drug’s mechanism of action, and courts look closely at whether the expert’s reasoning moves logically from that evidence to the conclusion.
The GLP-1 litigation shows how central this process can be. In the federal multidistrict litigation over gastrointestinal injuries, MDL No. 3094, the court scheduled hearings on expert testimony and general causation issues for September 2026, and the outcome of that phase will shape whether thousands of pending claims move forward. Here’s the kicker though. Those hearings focus largely on the science and leave the facts of individual plaintiffs for later stages, which means a single ruling on expert methodology can affect an entire docket.
If general causation evidence survives, MDL courts commonly move to bellwether trials, in which a small number of representative cases are tried to give both sides a sense of how juries respond. Expert testimony in those trials shifts toward specific causation, and the same experts who testified about the science in general may be cross-examined about how their opinions apply to one person’s medical history. Results from bellwether trials often influence settlement discussions across the entire docket.
Thyroid Cancer Questions
Thyroid cancer claims raise a distinct set of scientific questions. Semaglutide products such as Ozempic carry a boxed warning based on studies in which rodents developed thyroid C-cell tumors, and the label states that it is unknown whether the drug causes such tumors in humans. The drug is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Anyone evaluating an ozempic thyroid cancer lawsuit faces the question of how to bridge the gap between animal findings and human disease, since observational studies in people have reached mixed conclusions so far. That gap is exactly the kind of issue expert gatekeeping rules are designed to test.
Specific causation adds another layer. Thyroid cancer has several types and many possible risk factors, including radiation exposure and genetics, and an expert must explain why the drug best accounts for a particular patient’s illness when other possible causes are considered. Medical records showing when the drug was started, the type of cancer diagnosed, and the patient’s history all become central to that analysis.
Valuation Experts in Eminent Domain Cases
Eminent domain cases rely on a different kind of expert. When a government entity or authorized utility takes private property for public use, the Indiana Constitution and the federal Constitution require just compensation. Indiana’s eminent domain statute sets out a process that begins with an offer to purchase. If the owner does not accept, the condemning authority files a complaint, and the court may order the taking and appoint three disinterested residents of the county as appraisers to assess the damages.
Either side may file exceptions to the appraisers’ report, which leads to a trial on the amount of compensation, where a jury can decide the value. At that stage, competing real estate appraisers usually testify. They may use comparable sales, income capitalization for commercial property, or cost approaches, and they often disagree significantly. Owners working with an indianapolis real estate appraiser lawyer on a partial taking often find that the most contested issue is the damage to the remaining property, such as lost access, reduced frontage, or changes in visibility that affect a business.
Partial Takings and the Remainder
Funny thing is, the strip of land actually taken is sometimes the least valuable part of the claim. A highway expansion that takes a narrow strip along a commercial lot may eliminate parking, require relocating a sign, or change the driveway layout in ways that reduce the value of everything left behind. Indiana law allows compensation for that damage to the residue, and valuation experts must explain how the property’s value changed before and after the project. The government’s appraiser may argue the project creates benefits that offset some of that loss, which becomes another point of expert disagreement.
Valuation experts face the same reliability scrutiny as medical experts. An appraiser who relies on sales that are not truly comparable, ignores the property’s highest and best use, or fails to account for zoning and access restrictions can be challenged before trial or discredited on cross-examination. Owners and condemning authorities both exchange appraisal reports during discovery, and depositions of the appraisers often reveal the assumptions that drive the gap between their numbers. In many cases, that gap narrows considerably once each side has seen the other’s methods, and settlement follows.
Relocation adds a practical dimension for some owners. When a public project displaces a home or business and federal funds are involved, federal relocation assistance rules may provide payments for moving costs and certain related expenses, separate from the compensation paid for the property itself. Those payments do not depend on appraisal testimony, but they can affect how an owner evaluates an offer.
Where Specialized Knowledge Becomes Evidence
Drug causation and land valuation could hardly be more different as subjects, yet they share the same structure in court. In each, a judge must first decide whether an expert’s method deserves to be heard, and then a jury must decide which of the competing experts to believe. The ruling on reliability often comes long before trial and can end a case entirely. For people involved in either kind of dispute, the quality of the expert work frequently determines the outcome well before anyone takes the witness stand.
